Lot numbers can be found on the outside label of a product:
Please log in for operation!
*For research and further manufacturing use only, not for direct human use.
Structure of 2093387-36-9
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
Lenalidomide-Br features a brominated derivative of lenalidomide, incorporating a reactive bromine atom at the C5 position of the phthalimide ring. This modification enables site-specific conjugation in bioorthogonal labeling strategies and facilitates downstream derivatization for targeted drug delivery systems. The compound maintains the core pharmacophore essential for immunomodulatory activity while enhancing synthetic versatility.
Lenalidomide-Br serves as a versatile bromo-functionalized derivative of lenalidomide, enabling site-specific conjugation and downstream derivatization in medicinal chemistry workflows. Its reactive bromine atom facilitates palladium-catalyzed cross-coupling reactions, supporting the construction of diverse analogs for target validation and structure-activity relationship studies. The compound exhibits good bench stability and compatibility with common reaction conditions, making it a practical tool for scaffold diversification in oncology and immunomodulatory research.
|
GHS Pictogram :
|
GHS No : GHS07
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H302-H315-H319-H335
|
|
|
Precautionary Statements : P261-P280-P302+P352
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Lot numbers can be found on the outside label of a product: